REGEN BIOPHARMA, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
REGEN BIOPHARMA, INC. (RGBP) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$11.01 million for the 12-month period ending 2015-09-30, per its 10-K filed 2016-01-07.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-04-28
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-09-30 was -$661.55K.
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-06-30 was -$1.57M.
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2015-03-31 was -$8.58M.
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2014-12-31 was -$197.10K.
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$11.01M.
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$746.89K.
- REGEN BIOPHARMA, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$284.84K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 23 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 26 month |
|---|---|---|---|---|---|---|
| 2015-09-30 | -$661.55K derived: 10-K 12 month − 10-Q 9 month · filed 2016-01-07 | -$2.23M derived: sum of 2 quarters · filed 2016-01-07 | -$10.82M derived: sum of 3 quarters · filed 2016-01-07 | -$11.01M 10-K · filed 2016-01-07 | ||
| 2015-06-30 | -$1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-07-29 | -$10.15M derived: sum of 2 quarters · filed 2015-07-29 | -$10.35M 10-Q · filed 2015-07-29 | -$10.54M derived: sum of 4 quarters · filed 2017-04-28 | ||
| 2015-03-31 | -$8.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-07 | -$8.78M 10-Q · filed 2015-05-07 | -$8.97M derived: sum of 3 quarters · filed 2017-04-28 | -$9.14M derived: sum of 4 quarters · filed 2017-04-28 | ||
| 2014-12-31 | -$197.10K 10-Q · filed 2015-02-04 | -$387.47K derived: sum of 2 quarters · filed 2017-04-28 | -$555.86K derived: sum of 3 quarters · filed 2017-04-28 | -$750.89K derived: sum of 4 quarters · filed 2017-04-28 | ||
| 2014-09-30 | -$190.36K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-04-28 | -$358.76K derived: sum of 2 quarters · filed 2017-04-28 | -$553.79K derived: sum of 3 quarters · filed 2017-04-28 | -$746.89K 10-K/A · filed 2017-04-28 | ||
| 2014-06-30 | -$168.39K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-04-28 | -$363.42K derived: sum of 2 quarters · filed 2017-04-28 | -$556.53K 10-Q/A · filed 2017-04-28 | -$604.19K derived: sum of 4 quarters · filed 2017-04-28 | -$1.01M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | -$195.03K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2017-04-28 | -$388.13K 10-Q/A · filed 2017-04-28 | -$435.80K derived: sum of 3 quarters · filed 2017-04-28 | -$520.63K derived: sum of 4 quarters · filed 2017-04-28 | -$840.16K 10-Q · filed 2014-05-05 | |
| 2013-12-31 | -$193.10K 10-Q · filed 2015-02-04 | -$240.77K derived: sum of 2 quarters · filed 2015-02-04 | -$325.60K derived: sum of 3 quarters · filed 2015-02-04 | |||
| 2013-09-30 | -$47.66K derived: 10-K 12 month − 10-Q 9 month · filed 2014-12-18 | -$132.49K derived: sum of 2 quarters · filed 2014-12-18 | -$284.84K 10-K · filed 2014-12-18 | |||
| 2013-06-30 | -$84.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-07 | -$237.17K 10-Q · filed 2014-08-07 | ||||
| 2013-03-31 | -$152.34K 10-Q · filed 2014-05-05 |